TSG101 Antikörper (C-Term)
Kurzübersicht für TSG101 Antikörper (C-Term) (ABIN7185626)
Target
Alle TSG101 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- TSG101 Antibody
-
Kreuzreaktivität
- Affe, Maus, Ratte
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of Human Tsg 101.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TSG101 (Tumor Susceptibility Gene 101 (TSG101))
-
Andere Bezeichnung
- TSG101
-
Hintergrund
- ESCRT I complex subunit TSG101 antibody, ESCRT-I complex subunit TSG101 antibody, TS101_HUMAN antibody, TSG 10 antibody, TSG 101 antibody, TSG10 antibody, Tsg101 antibody, Tumor susceptibility 101 antibody, Tumor susceptibility gene 10 antibody, Tumor susceptibility gene 101 antibody, Tumor susceptibility gene 101 protein antibody, Tumor susceptibility protein antibody, Tumor susceptibility protein isoform 3 antibody, VPS 23 antibody, VPS23 antibody
-
UniProt
- Q99816
Target
-